Combination of HBsAg Level and Hepatitis B Viral Load at Week 12 is the Best Stopping Rule for Chronic Hepatitis B, HBeAg Positive Patients Treated With Peginterferon ALPHA-2A

被引：0
|
作者：
Phisalprapa, Pochamana
Tanwandee, Tawesak
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S954 / S955
页数：2
相关论文
共 50 条
  • [41] Association between HBeAg seroconversion and sustained HBV-DNA suppression in patients treated with peginterferon alpha-2a (40KD) (PEGASYS) for HBeAg-positive chronic hepatitis B (CHB)
    Piratvisuth, T.
    Lau, G. K. K.
    Marcellin, P.
    Chow, W. C.
    Cooksley, G.
    Fried, M. W.
    Paik, S. W.
    Liaw, Y. F.
    Popescu, M.
    Button, P.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S23 - S23
  • [42] Modeling of pharmacokinetics and viral kinetics in HBeAg-positive chronic hepatitis B treated with pegylated interferon alpha-2b
    ter Borg, M. J.
    Hansen, B. E.
    Herrmann, E.
    Zeuzem, S.
    Haagmans, B. L.
    Janssen, H. L. A.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (10) : A71 - A72
  • [43] Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a
    Rijckborst, Vincent
    Hansen, Bettina E.
    Ferenci, Peter
    Brunetto, Maurizia R.
    Tabak, Fehmi
    Cakaloglu, Yilmaz
    Lanza, A. Galeota
    Messina, Vincenzo
    Iannacone, Claudio
    Massetto, Benedetta
    Regep, Loredana
    Colombo, Massimo
    Janssen, Harry L. A.
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2012, 56 (05) : 1006 - 1011
  • [44] Modeling of pharmacokinetics and viral kinetics in HBeAg-positive chronic hepatitis B treated with pegylated interferon alpha-2b
    ter Borg, Martijn J.
    Hansen, Bettina E.
    Herrmann, Eva
    Zeuzem, Stefan
    Haagmans, Bart L.
    Janssen, Harry L.
    HEPATOLOGY, 2006, 44 (04) : 566A - 567A
  • [45] Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon
    Wang, Gui-Qiang
    Hou, FengQin
    Xia, NingShao
    HEPATOLOGY, 2014, 60 : 1110A - 1111A
  • [46] Quantitative Hepatitis B Core Antibody Level Is a New Predictor for Treatment Response In HBeAg-positive Chronic Hepatitis B Patients Receiving Peginterferon
    Hou, Feng-Qin
    Song, Liu-Wei
    Yuan, Quan
    Fang, Lin-Lin
    Ge, Sheng-Xiang
    Zhang, Jun
    Sheng, Ji-Fang
    Xie, Dong-Ying
    Shang, Jia
    Wu, Shu-Huan
    Sun, Yong-Tao
    Wei, Shao-Feng
    Wang, Mao-Rong
    Wan, Mo-Bin
    Jia, Ji-Dong
    Luo, Guang-Han
    Tang, Hong
    Li, Shu-Chen
    Niu, Jun-Qi
    Zhou, Wei-dong
    Sun, Li
    Xia, Ning-Shao
    Wang, Gui-Qiang
    THERANOSTICS, 2015, 5 (03): : 218 - 226
  • [47] Characterization of Hepatitis B Surface Proteins in HBeAg-positive Patients with Chronic Hepatitis B (CHB) Treated With PegInterferon Alfa-2a (40KD)
    Rinker, Franziska
    Bremer, Corinna M.
    Wiegand, Steffen B.
    Bremer, Birgit
    Manns, Michael P.
    Wedemeyer, Heiner
    Yang, Lei
    Pavlovic, Vedran
    Wat, Cynthia
    Glebe, Dieter
    Kraft, Anke R.
    Cornberg, Markus
    HEPATOLOGY, 2015, 62 : 1196A - 1197A
  • [48] HBeAg INDEX AND HBV DNA REDUCTION CAN PREDICT LONG TERM RESPONSE OF CHRONIC HEPATITIS B, HBeAg POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALPHA-2a: A THREE-YEAR FOLLOW-UP
    Phisalprapa, P.
    Charatcharoenwitthaya, P.
    Chainuwatti, S.
    Chotiyaputta, W.
    Nimanong, S.
    Tanwandee, T.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S203 - S204
  • [49] PREDICTORS OF DEVELOPMENT OF HBEAG-NEGATIVE CHRONIC HEPATITIS B FOLLOWING PEGINTERFERON ALFA-2A THERAPY IN HBEAG-POSITIVE CHRONIC HEPATITIS B
    Peng, Cheng-Yuan
    Shih, Chao-Jen
    Lo, Pei-Shuan
    Huang, Chia-Lin
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Chuang, Po-Heng
    Kao, Jung-Ta
    HEPATOLOGY, 2011, 54 : 1027A - 1028A
  • [50] VIRAL DYNAMICS AND EARLY VIRAL RESPONSE AT WEEK 4 IN CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGINTERFERON α2B AND RIBAVIRIN
    Loaeza del Castillo, Aurora
    Sixtos-Alonso, S.
    Sanchez-Avila, F.
    Uribe, M.
    HEPATOLOGY, 2009, 50 (04) : 965A - 965A
12345